× Home Projects Partners Special Events FAQs Contacts
ihi-logo

TALK: Exploring the current state of TB and NTDs research with the Swiss TPH

Feb. 4, 2025 4:53
TALK:  Exploring the current state of TB and NTDs research with the Swiss TPH
Graphic: Ifakara Communications

Ifakara Health Institute hosted virtual talk on the “Current State of Epidemiology, Diagnostics, and Research on Tuberculosis” and “Neglected Tropical Diseases: The Impact of Schistosomiasis and Soil-Transmitted Helminthiasis on Sustainable Development Goals” in collaboration with the Swiss Tropical and Public Health Institute (Swiss TPH). The session tool place on Friday, February 7, 2025, at 3:30 PM EAT.

This engaging discussion featured leading experts from Swiss TPH, including, Prof. Jürg Utzinger, the Director of the Swiss Tropical and Public Health Institute (Swiss TPH)Sébastien Gagneux (Head of Department of Medical Parasitology and Infection Biology - Swiss TPH) , Klaus Reither (Head of Clinical Research Unit and leader of Clinical TB Research Group - Swiss TPH), Damien Portevien (Research Scientist - Swiss TPH) and Dr. Jerry Hella from Ifakara Health Institute.

Designed as an interactive virtual session, participants had the opportunity to engage directly with the speakers, ask questions, and contribute to meaningful discussions around TB research and advancements.

SwissTPH Director Urges More Research on TB and NTDs

Prof. Jürg Utzinger, Director of the Swiss Tropical and Public Health Institute (SwissTPH), called for increased research efforts and urged young scientists to engage in studying NTDs to make a difference. He emphasized that a deeper understanding of these diseases is crucial for developing effective strategies to combat and eliminate them.

The discussion featured leading experts from SwissTPH, including Sébastien Gagneux, who explored the origins of M. tuberculosis and the role of human ancestry, with insights from Tanzania. Klaus Reither highlighted the significance of asymptomatic (subclinical) TB, shedding light on its impact on disease transmission and control. Damien Portevien provided insights into TB immunology, emphasizing the need for better understanding immune responses to improve treatment and prevention.

A key takeaway from the discussion was the need to recognize and address asymptomatic TB cases. Experts stressed the importance of better screening methods, tailored treatments, and incorporating these cases into vaccine research to enhance TB control and elimination efforts.